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1. Introduction 
The first description of surgery for rectal cancer was reported by the French surgeon 
Lisfranc who described a total of nine patients operated trough a perineal-transanal 
approach (Lisfranc, 1830). Although more recently gaining popularity, transanal techniques 
have long been used for the treatment of rectal diseases and were promoted by the work of 
Sir Alan Parks at St. Marks Hospital in London in the 1950s (Parks, 1970). This conventional 
surgical approach is well suited for the management of selected low rectal lesions; on the 
contrary, removal of lesions in the middle and upper rectum are less feasible due to the 
limited accessibility and inadequate exposure afforded by standard instrumentation. For 
these reasons, those more proximal lesions have historically been tackled by more radical 
surgical approaches, like abdominal low anterior, abdominoperineal, transsacral, and 
transsphincteric resections.  
 
 
Fig. 1. J. Lisfranc’s description of surgery for rectal cancer. 
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Transanal endoscopic microsurgery (TEM) came into practice in Germany, in the early 1980s 
through the collaboration of the German surgeon Gerhard Buess and the Medical Company 
Richard Wolf (Buess et al., 1984). Its initial indication was to remove large rectal polyps 
beyond the reach of standard transanal excision. TEM is a technique for the performance of 
local excision, by the way of a binocular, magnified operating system. This equipment 
involves an operating proctoscope, insufflation, and magnified stereoscopic vision. In fact, 
the three-dimensional amplification, magnified stereoscopic view and lighting within the 
rectal lumen, allow excellent vision of the operative field, enabling the surgeon to perform 
an extremely precise excision of rectal lesions, including a full-thickness excision. It has 
evolved into a valuable, state-of-the-art technology equaling any other technique in terms of 
reliably positive patient outcome. Its application has expanded beyond the excision of 
colonoscopically unresectable polyps to the removal of select, early rectal cancers, 
independent of prior adjuvant chemoradiation therapy. Further fields of use include the 
treatment of anastomotic strictures, and repair of proximal, complex rectal fistulae. TEM 
allows greater flexibility and options for the operating surgeon. In addition to extending the 
surgeon’s reach up to the distal sigmoid colon, the four ports of access allow for 
concomitant use of an illuminated camera, forceps, cautery, suction as well as the freedom 
to apply common laparoscopic techniques such as suturing and different energy sources.  
TEM has been found useful in the treatment of a broad variety of disease processes, both 
benign and malignant. Though many indications have been described, including excision of 
carcinoids or even retrorectal tumors, the most common use of TEM remains the resection of 
colonoscopically unresectable rectal adenomas and carefully selected rectal cancers. It 
should be stressed that even though TEM extends the reach of conventional transanal 
resections, it should not lead to any deviation from the established stringent indications for 
resection, especially in regard to rectal cancer (Palma et al, 2004). 
Due to the limited visibility and access inherent to traditional transanal retractors, use of the 
latter has been restricted to the resection of low rectal polyps and suitably located early 
cancers. The TEM technique grants access to the entire rectal cavity, facilitating the reach of 
lesions with their proximal margin located as far as 20 cm from the anal verge. Some of the 
limitations of TEM are due to the surgeon’s personal skills and experience. The conditions 
treated by TEM, namely, colonoscopically unresectable rectal polyps and early cancers, are 
far less common in terms of incidence and epidemiology, than those treated by abdominal 
laparoscopic operations, thus limiting any single surgeon’s or institution’s volume and 
operative experience.  
Contemporarily several factors have induced a new interest for TEM among practitioners, 
predominantly due to surging controversy about increased local recurrence rates following 
standard transanal resection of favorable early stage rectal cancers. TEM bears some 
advantage over standard transanal excision of neoplasms, including better visualisation of 
the surgical field and tumor margins. Inflicting fewer traumas, the probability of tumor 
fragmentation and dissemination diminishes, while additionally enabling resection of the 
potentially infiltrated mesorectum. As a matter of fact, more and more surgeons are being 
trained with advanced endoscopic skills. Synergistically these skills make handling the TEM 
equipment more feasible and surgeons face a less steep learning curve, generally promoting 
the use of the procedure. 
Also, the use of TEM may not be restricted to the anal cavity, but serve as a gateway to the 
peritoneum for natural orifice transluminal endoscopic surgery (NOTES). Transrectal access 
to the peritoneum via TEM has the future potential to facilitate the removal of larger organs, 
www.intechopen.com
 Transanal Endoscopic Microsurgery - State of the Art 
 
59 
maintenance of pneumoperitoneum, endoscopical visualisation of upper abdominal organs 
and secure suture closure of the proctotomy, by the application of larger, more versatile 
instruments.  
2. TEM Equipment 
2.1 Articulated stabilising arm 
The proctoscope is aligned using an articulated arm, also known as the Martin arm, which is 
firmly attached to the operating table (figure 2). There are two ball joints which fully 
articulate and are locked into place with a single set screw. A bar at the one end of the 
articulated arm attaches to the rail on the operating table. At the opposite end the articulated 
arm attaches to the operating proctoscope. 
 
 
Fig. 2. Martin articulated arm. 
2.2 Operative proctoscopes 
The diameter of the operating proctoscope is 4 cm, it is available in two different lengths, 
10 and 20 cm and allows access throughout the rectum. A rotating collar on the handle 
locks the scope shaft, creating an airtight seal. The handle comes with a port, allowing  
the attachment of a hand-bulb insufflator or a tube for monitoring the CO2 pressure 
(figure 3).  
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Fig. 3. TEM operating proctoscope (20 cm) with hand-bulb insufflator. 
A faceplate is fitted to the handle and locked with an sealed lever. This faceplate has a port 
for the optics and three rubber caps for the long operating instruments (figure 4). These 
ports are able to maintain pneumorectum and are fitted with holes of varying size, to 
accommodate instruments of different diameters. The right-side operating port is slightly 
larger and thus requires a slightly larger cap. Flap valves in the snap-on multiport piece 
serve to help prevent gas leaks. 
 
 
Fig. 4. TEM faceplate with four ports. 
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2.3 Optics 
A 10-mm stereoscope which provides a high-definition, three-dimensional view is used. The 
stereoscope’s long, rigid shaft is inserted into the optic port on the faceplate and extends the 
entire length of the operating proctoscope.  
A 40o, 5-mm scope is inserted into the stereoscope and connected to a camera, allowing a 
live feed from the rectal cavity to be displayed on a video monitor. The stereoscope also has 
two ports serving for water irrigation and CO2 insufflation (figure 5). 
 
 
Fig. 5. TEM proctoscope (above) and 10 mm stereoscope (below), attached to a 5 mm scope 
for video viewing. 
2.4 TEM Instruments 
Long instruments are needed access the surgical field via the operating TEM proctoscopes 
(figure 6). The instruments include electrocautery, forceps, scissors, suction probe, clip 
applier, needle holder, and retractable needle. 
There are two variants of forceps, either straight or angled. Both types are provided on 
instruments with tips facing either left or right. Each instrument may be electrified 
individually. Also the scissors are provided with the tip facing either left or right, and are 
mainly used for cutting sutures. 
The suction probe is a, double-curved, rigid tube designed to be inserted through the 
proctoscope and sit on the side of the scope’s channel , not to obstruct vision during the 
procedure.   
The needle device has a retractable needle within the tip of the rigid tube and may be 
extended or retracted with a syringe type handle. The needle holders are available with 
either a straight or an angled tip. The angled tip provides a slightly wider arc when passing 
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a needle. In addition the jaws are ‘‘self-righting’’, when the needle is grasped it will rotate 
into the proper orientation by itself. The needle can be locked into position with a rotating 
ratchet controlled by the surgeon’s thumb. The lock is released by over-squeezing the 
handle, allowing the surgeon to safely handle the needle. 
The clip applier is a unique instrument which crimps a small silver clip onto the suture. 
Replacing the need for knot tying, clips are placed at the beginning and the end of running 
suture. 
 
 
Fig. 6. TEM distal proctoscope opening showing the stereoscope together with forceps and 
suction probe. 
2.5 Specific TEM devices 
The specific device providing CO2 insufflation, water injection, and suction is stacked on a 
suitable portable cart (figure 7) as well as the video monitor, recorder and light source 
(figure 8). An electrocoagulation unit may be placed in the stack or a separate standard 
operating room unit may be employed.  
 
 
Fig. 7. Specific device for CO2 insufflation, water injection and suction. 
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The insufflator injects CO2 via a port on the stereoscope’s optic shaft. Lighting is supplied 
via a fiberoptic cord leading to a connector on the optic probe. Water irrigation may be 
engaged using a pedal. The water for irrigation flows through the stereoscope’s shaft and is 
diverted across the optic tip, thus keeping the view clear.  
 
 
Fig. 8. The video monitor, recorder and light source are stacked on a portable cart. 
2.6 Surgical set-up 
Assembling the equipment can be time-consuming. The surgeon must position the patient 
in such way, that the tumor faces down directly towards the operating table; the choice of 
position is based upon prior examination in the office with a rigid proctoscope locating the 
tumor at both a specific level and a specific site on the circumference. 
The patient may be placed in the lithotomy position, prone, or laterally; for a tumor that is 
almost circumferential the patient may need to be turned during the procedure. In our 
experience, the patient must be secured to the table with a bean bag, as the table may need 
to be rotated to bring the tumor into the center of the field. After positioning the bean bag, 
the articulated arm is attached to the operating table. The four tubes leaving the 
insufflation/suction devices must be connected properly. 
Figure 9 shows the operation theatre setup with the patient in prone postion in order to 
reach the neoplasm, located on the anterior rectal wall. 
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Fig. 9. Surgical setup with the patient in prone position 
In conclusion, TEM requires specialized equipment and training. In addition to technical 
expertise, the dedicated TEM colorectal surgeon should be familiar with the necessary 
instruments and electronic devices. Expertise in troubleshooting is particularly helpful. 
There is, however, no substitute for a dedicated operating room team to ensure an efficient 
and successful TEM procedure.  
3. Surgical technique 
Preceding the procedure, bowel cleansing and prophylactic antibiosis have to be performed. 
In the actual procedure, two different operation techniques can be employed. Mucosectomy 
involves removing the mucosa, including the polyp from the inner circular layer of the 
muscularis; it represents a suitable technique for sessile adenomas located in the 
intraperitoneal portion of the rectum. 
Full-thickness excision requires removal of all layers of the rectal wall, in the plane located 
just slightly superficial of the perirectal fatty tissue. This excision is performed for the 
majority of malignant lesions. 
 
 
Fig. 10. Surgical dissection of an adenoma with two large TEM instruments. 
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In cases of malignancy, it is imperative that the procedure includes not only a full-thickness 
excision but also a 1 cm safety margin of normal mucosa surrounding the lesion. 
 
 
Fig. 11. TEM full-thickness dissection of rectal adenoma, showing the perirectal fatty tissue. 
It is of crucial importance to correctly align the specimen on the cork board immediately 
after resection, to evaluate the safety margins before fixation with formalin. The proximal 
and distal margins of resection have to be identified to ensure correct histologic 
examination.  
The rectal defect is closed by a running suture with a polydioxanone (3/0) monofilament 
and has to be performed transversely to prevent stenosis. The application of a silver clip at 
each end of the suture avoids the need for intraluminal knotting.  
Alternatively, recent reports indicate the possibility to leave the defect open for secondary 
wound repair, especially in cases of partial-thickness excision. 
 
 
Fig. 12. Rectal wall defect closed by a running suture. Please note the peritoneal opening. 
Patient in the prone position.  
www.intechopen.com
 Therapeutic Gastrointestinal Endoscopy 
 
66
Following the excision of large masses, mobilization of the proximal and distal rectal wall 
will minimize tension on the suture line (figure 13). Approximating large defects with a 
single suture at the midpoint, facilitates the closure.  Following this, the defect is closed from 
the peripheral margins to the center in running fashion. In our experience, modern 
instruments like the endo-stitch™ (Covidien) are well suited to perform the running suture. 
 
   
Fig. 13. Large rectal mass excision resulting in a ¾ defect to be closed. 
4. Patient selection and staging 
Resection of rectal and distal sigmoid adenomas is the most prominent indication for TEM. 
These benign lesions do not require mesorectal dissection, thus patients can be spared the 
morbidity of an unnecessary radical intervention. Smaller adenomas without evidence of 
high-grade dysplasia may be removed by partial-thickness (submucosal) excision. Larger 
adenomas or those with high-grade dysplasia are at high risk of containing invasive 
adenocarcinoma loci and should be excised full-thickness with a 10 mm resection margin. 
 
 
Fig. 14. Adenoma specimen after TEM excision. 
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Resection of anterior rectal lesions requires special care. Full-thickness excision of the 
anterior and even lateral rectum carries the risk of unnoticed dissection into the vagina, 
urethra, or bladder. In this case, failure of adequate closure may lead to a rectourethral or 
rectovaginal fistula. 
Intraperitoneal entry carries a risk of injuring intraabdominal structures, bacterial and 
potential cytologic contamination, as well as anastomotic leakage. Initially regarded as a 
complication, intraperitoneal excision with secure closure of the rectal defect has been 
performed with growing experience, without increased short-term morbidity (figure 12). 
In case of a suspicious rectal polyp with unconfirmed malignancy in a patient unfit for or 
unwilling to undergo major abdominal surgery, TEM can be useful in resecting the entire 
lesion in one piece for complete histologic assessment. Salvage radical surgery, if indicated, 
can be performed thereafter without significantly increasing morbidity. TEM may also be 
useful as a palliative tool in patients with extensive metastatic disease or those medically 
unfit to withstand radical surgery. Neoadjuvant radiation therapy, when used in 
conjunction with resection, either aiming for cure or palliation, does not appear to increase 
complications following TEM. 
Accuracy in the preoperative staging is mandatory to correctly select patients eligible for 
local excision. The routine use of endorectal ultrasound (figure 15), in combination with 
magnetic resonance imaging (MRI) has revolutionized our ability to perform accurate 
preoperative staging with respect to rectal wall penetration (T stage) and regional lymph 
nodes (N stage) (figure 16). 
 
 
Fig. 15. 3D endorectal ultrsound showing a rectal mass without disruption of any of the 
rectal wall’s layers. 
Only patients with negative lymph nodes, a tumor limited to the wall of the rectum, 
presenting a diameter not exceeding 3 cm (in cases of malignancy), should be considered 
eligible for local excision. 
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Fig. 16. Pelvic MRI T2 sequence, axial plane showing a rectal mass with a lymph node in the 
mesorectum. 
 
 
Fig. 17. Histopathological specimen obtained from the patient mentioned above, showing 
both the rectal mass and the mesorectal lymph node in contact with the mesorectal fascia.  
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Preoperative staging workup includes: 
 Digital rectal examination 
 Colonoscopy 
 Rectoscopy, to:  
1. Perform biopsies 
2. Measure the distance from the anal verge to the lesion 
3. Evaluate the circumferential position of the tumor 
4. Select an appropriate patient positioning for TEM approach 
 Endorectal ultrasound 
 Pelvic-MRI 
 18F-FDG PET-CT, specifically in our institution (figure 18). 
 
 
Fig. 18. 18F-FDG PET-CT showing pathologic intense glucose uptake due to rectal cancer. 
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Each biopsy is examined by a dedicated pathologist to assess the tumor grade, as well as the 
lymphatic, neural, and blood vessel infiltration. 
5. Current indications and results 
Results from our experience and others are evaluated in the following chapter 
5.1 TEM for benign lesions 
Benign rectal tumors that are not suitable for snare diathermy excision are often amenable to 
removal via the transanal route, employing anal retractors and Parks’s method (Parks, 1970). 
However, this method is limited to the lower third of the rectum. In addition, it may be 
difficult to visualize the margins of flat adenomas.  
Conventional management of higher rectal lesions usually involves transabdominal 
procedures, posterior trans-sacral (Kraske), or sphincter-splitting (York-Mason) approaches. 
However, these are major surgical procedures with associated complications and may be 
unsuitable and unnecessary if the purpose of the intervention is to resect benign lesions or 
low risk carcinomas. 
With the development of TEM by G. Buess (Buess et al., 1984), it is now possible to carry out 
formal transanal resection by means of a rectoscope, which affords excellent access and 
vision in the entire rectum.  
According to our experience, we recomend a full-thickness resection, to ensure an 
appropriate margin of safety. In addition, we found that this standard procedure is 
technically easier to perform than mucosectomy and that it decreases the risk of missing a 
small rectal cancer which may be located within the villous adenoma. Such ‘intraephitelial 
neoplasia ⁄ dysplasia’ or ‘early invasion’ has been reported in up to 31% of cases. 
Although it is often difficult to ascertain the precise techniques (full-thickness or 
submucosal) used, the rates of complete excision at the time of operation and the exact 
follow up, large published series report a rate of recurrences in up to 27.3% after transanal 
excision of rectal adenomas (Sakamoto et al., 1991). In contrast the results reported using 
TEM show a recurrence rate between 3 and 7% with the 5.6% for the adenoma cases of our 
series pubished in 2004, being well in accordance with previous studies (Palma et al., 2004). 
The overall morbidity rate for conventional transanal surgery in reported series varies from 
0 to 14.5%, compared with 6% reported in the largest series of a total of 318 adenomas 
treated by Mentges (Mentges et al., 1996). These results are in accordance with others TEM-
series reporting morbidity of up to 4.5% in more than seven hundred patients and with our 
own experience (7%).  
It is of interest that postoperative bleeding is unusual with TEM, whereas it accounts for 
over half of the complications reported in other series (Sakamoto et al., 1991). Peritoneal 
entry, on the other hand, as assessed intra-operatively in 8 patient of our published 
experience (two of them with postoperative pneumoperitoneum), can be a significant source 
of morbidity with TEM. Presumably the excellent vision afforded by TEM allows more 
precise haemostasis, whereas the ability to excise high rectal lesions increases the likelihood 
of peritoneal entry, especially when the tumour is anterior, and thus more likely to be above 
the peritoneal reflection. In our experience, all perforations were recognized and managed 
by immediate endorectal suture (fig. 12). 
Our results after initial 100 cases with TEM indicate that this technique is reproducible with 
suitable surgical training.  
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Interestingly all three protective ileostomies in our series occurred within the first 20 cases 
indicating a learning curve, despite the fact that all surgeons received a special TEM 
training. 
Regarding the effect of a prolonged anal dilatation with the 40 mm diameter TEM operative 
rectoscope, manometric studies indicate a decrease in anal sphincter tone ranging from 25% 
to 37% of pre-operative sphincter pressure, with recovery to clinical continence within 6–16 
weeks (Herman et al., 2001). We observed postoperative transitory grade II incontinence in 
65 of the 100 patients, with full recovery in 98% of the cases after 12 weeks. There is also 
evidence indicating a significantly increased risk of diminishing the anal resting pressure by 
procedures lasting more than two hours. Others found 21% disturbances of rectoanal 
coordination and rectal perception, depending on the extent and type of resection of the 
tumor. However, when making continence judgement, it would be necessary to consider the 
risk of incontinence by using the Parks retractor in conventional surgery, or after a low 
restorative rectal excision, if those were to be the alternative procedures. 
In conclusion, TEM as a minimally invasive technique might be expected not only to benefit 
a small, specific population of patients in terms of morbidity but also to improve results in 
terms of completeness of excision and recurrence rates when compared to conventional 
transanal resection. 
5.2 TEM for early rectal cancer 
The standard treatment for early rectal cancer has been major surgery by anterior or 
abdominoperineal resection. After the introduction of total mesorectal excision, results 
regarding recurrence and survival rates have improved dramatically (figure 19). However, 
mortality, morbidity, and functional disturbances after major surgery are considerable. 
Perioperative mortality rates are usually 2 to 3 percent and overall morbidity 20 to 30 
percent. Furthermore, anorectal, bladder, and sexual function may be compromised. 
 
 
Fig. 19. Total mesorectal excision specimen 
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Given these side effects, there has been an increasing interest in the locoregional treatment 
of early rectal cancer. Nowadays local excision for selected rectal neoplasms is an accepted 
treatment worldwide (Bretagnol et al., 2007). Compared to the gold standard of radical 
surgery, local procedures of strictly selected early rectal cancers should lead to identical 
oncological results and even better outcomes regarding morbidity, mortality, and quality of 
life. 
Regardless of this trend, conventional transanal excision of rectal cancer has recently come 
under close scrutiny because of relatively high rates of local recurrence (Bentrem et al., 2005). 
In fact, scepticism has been expressed that such treatment may not be in the patient’s best 
interest. Despite all these concerns transanal endoscopic microsurgery has become the current 
standard procedure for the treatment of large rectal adenomas and early low risk carcinomas 
with curative intent, mostly in Europe (Demartines et al., 2001, Palma et al., 2004).  
As already assessed and in contrast to conventional transanal excisions using anal retractors, 
TEM offers an exceptionally good overview of the whole rectal cavity, allowing the precise 
removal of lesions not only in the lower and middle rectum but also in the upper region or 
even the retrorectal space, and obviates the need for major surgery. 
Despite the limitations and the lack of power of clinical studies to detect differences in 
outcome such as survival and complication rates, TEM does appear to result in less local 
recurrence than other usual methods of local excision.  
Furthermore, after local excision of early rectal cancer by TEM, recurrence and survival rates 
are comparable to those seen after major surgery, and complication rates and functional 
results are even superior when put into contrast with those seen after major surgery 
(Middleton et al., 2005). 
Since the introduction of TEM in our Division of Colon & Rectal Surgery a majority of 
patients with adenomas and T1 low-risk rectal cancer have been treated with local excision 
by this technique (Palma et al., 2004).  
In 2009 we ran a single center report to evaluate the safety and oncological outcomes of TEM 
excision compared to radical surgery (RS) in the treatment of T1 low-risk rectal cancer. We 
found no statistical differences between RS and TEM in terms of local recurrence and 
disease free survival rates (Palma et al., 2009). 
Today, various surgical techniques are still under discussion for the treatment of early rectal 
carcinomas. The historical gold standard procedures, such as anterior and 
abdominoperineal resection, show excellent results regarding local recurrence and survival 
rates, but are dearly paid for by a high incidence of complications and impaired quality of 
life (anorectal, sexual, and urinary dysfunction). Additionally, some of the patients require 
temporary diverting enterostomies. On the other hand, there are conventional, sphincter-
preserving techniques, such as conventional transanal resection with Park’s retractor (Parks, 
1970), which are associated with an almost unacceptably high local recurrence rate of up to 
29% (Madbouly et al., 2005).  
The primary factor limiting the effectiveness of local treatment for early rectal cancer is 
lymph node invasion. Depths of invasion into the rectal wall, grade or degree of 
differentiation, vascular, lymphatic and neural invasion are independent predictors of the 
risk of nodal metastasis. 
Since initial studies by Morson (Morson, 1985) and Hermanek (Hermanek & Marzoli, 1994) 
large series of resected rectal cancers have shown that well-differentiated tumors confined to 
the submucosa (T1) without vascular, lymphatic or neural invasion carry a 4% risk of nodal 
metastasis. 
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Although the reported rate of recurrence for early rectal cancers (pT1) resected by TEM is 
between 4- and 14%, follow-up and differentiation between low- and high-risk features are 
variable among series reported. In fact, the only published prospective study comparing 
TEM with radical resection for T1 low risk rectal cancer showed no statistical difference 
between local excision and radical resection regarding local recurrence and metastasis rate 
(Winde et al., 1996). These results are in accordance with our observations. We assessed two 
recurrences in the TEM group compared to none in the RS group. Local control is therefore 
undoubtedly better assessed after RS, but on the other hand it is interesting to underline that 
there was no statistically significant difference in overall survival and disease-free survival 
depending on the operation performed. 
In an outstanding systematic review published recently, both comparative and case-series 
studies were examined to assess evidence related to the safety and efficacy of TEM 
compared with radical resections and conventional local excisions ((Middleton et al., 2005). 
Despite limited evidence the authors pointed out the unequivocal tendency of TEM to 
achieve better results in well-selected cases than conventional local excision, without being 
less effective than radical resection. The question arising is, whether TEM represents the 
only adequate alternative to radical resection for early rectal cancer. 
The reason for the superiority of TEM over other transanal conventional techniques is the 
use of an optical system with 3D-view, 6-fold magnification, and human eye resolution; the 
creation of a stable pneumorectum, and specially designed instruments that allow full-
thickness excision under excellent view conditions not only in the lower but also in the 
middle and upper parts of the rectum. Furthermore, full-thickness excision allows proper 
histological examination. 
Recently we showed the ability and advantages of this technique to approach tumors 
located in the retrorectal space (Zoller et al., 2007). 
The advantage of TEM has already been observed in the lower rate of recurrences for 
adenoma excision (up to 7%) when compared to recurrence rate after transanal conventional 
excision (up to 27.3%). Even for adenomas, completeness of excision is an important 
predictor for early recurrence. Furthermore, the literature reported a lower morbidity rate 
when using TEM for adenoma excision (7% complication rate compared to 14.5% for 
conventional transanal surgery) (Ganai et al., 2006). 
Surprisingly many publications still advocate for caution in the local excision of rectal 
cancer. However, these studies are questionable regarding selection criteria, use of 
endorectal ultrasounds preoperatively, proper “in toto” excision, and histological 
examination (R-Status, differentiation, and lymphovascular invasion).  
In addition, some data is compromised by mainly retrospective analyses over extended time 
periods, and by a lack of standardized pathology reports. 
The main argument explaining the high rate of local recurrences after conventional local 
excision could be a technically inadequate operation in which margins are insuficcient, 
inadequate depth of resection, or shedding and implantation of tumor cells into the surgical 
field (Cataldo, 2006). 
Moore (Moore et al., 2008) compared 82 patients after TEM with another 89 after 
conventional transanal excision for rectal neoplasms. He found clear margins in 71 percent 
of specimens in the conventional group compared with 90% in the TEM group. 
Furthermore, non fragmented specimens were more likely to be found after TEM than after 
conventional surgery (94 vs. 65 percent). In our hands the rate of Rx and R1 after local 
excision was 5.88 and 2.94%, respectively. 
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We believe that strict patient selection criteria, together with full-thickness and margin-free 
excision is crucial for patient outcome. The strong correlation between incomplete tumor 
resection and poor outcome is widely accepted. In our experience, positive excision margins 
should not be regarded as a risk factor for recurrence but should be viewed as insufficient 
therapy requiring further treatment.  
Therefore, accurate pathological examination after corkboard fixation of the specimen, and 
intensive, close cooperation between surgeon and pathologist cannot be overemphasized. 
Although local recurrence was only observed after local excision, patients treated with TEM 
in our hands showed no significant differences in terms of overall survival and disease-free 
survival, as compared to patients who underwent RS. As local excision represents a 
minimally invasive technique in terms of morbidity, mortality and functional outcome, TEM 
should be offered as a valid option for well-selected patients with early rectal cancer. 
Despite the difficulty to perform further studies in the future, comparing different methods 
of local excision with more radical procedures and the possible combination of neoadjuvant 
chemoradiation for better local and distant control even for high risk tumors (Borschitz et 
al., 2008), we can conclude following our published experience, that TEM should be 
considered as best practice to perform a local excision of well selected cases of early rectal 
carcinoma. 
5.3 TEM in rectal cancer after chemoradiation 
Although adjuvant or neoadjuvant chemoradiotherapy seems to improve the prognosis 
after local excision, the indications for any kind of therapy following local resection of rectal 
cancer by TEM remain controversial. In fact, local treatment of rectal cancer is limited by the 
impossibility of removing the potentially positive lymph nodes, supporting the concept of 
adjuvant radiotherapy, chemotherapy, or both to achieve local control of the lymph nodes.  
Borschitz (Borschitz et al., 2008) published a review of the findings of neoadjuvant 
chemoradiation (nCRT) and local excision (LE) for T2–3 rectal carcinoma. He found a total of 
237 patients in seven different studies available for analysis, which did in fact permit an 
assessment of the recurrence rates in relation to histopathological tumor response.  
Patients with systemic metastases were excluded, and lymph node status was provided by 
only a few authors.  
In most studies analysed, clinical staging before nCRT identified a T2/3 rectal carcinoma (T1 
2%; T1–2 14%; T2 34%; T3 50%).  
The studies reported different therapeutic concepts, tumor locations, and intervals from 
completion of nCRT to surgery. Nevertheless, the analysis by Borschitz identified a number 
of similarities among them. These were predominance of cT2–3 carcinomas and the 
occurrences of local recurrence (LR). Patients with response at the submucosa level (ypT1) 
consistently showed low LR rates of 2% (0%–6%).  
Less clearly defined were the results of ypT2 findings, which ranged from 6% to 20% LR 
rates. Clearly unfavorable were the findings in patients, whose disease did not respond to 
therapy (ypT3), for whom a mean LR rate of 21% was calculated. The widely divergent LR 
rates of ypT2 findings may be increased as a result of to nonuniform time intervals from 
nCRT to surgery.  
The study by Borschitz confirms prior findings observed after nCRT and conventional 
resection. Almost no LR were reported for CR after nCRT of advanced (T3/4) tumors. 
Critical prognostic parameters are tumor response and tumor- free lymph nodes. LR and 
systemic recurrence rates ranging 0% to 23% and 8% to 22% were determined for this 
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constellation. For lesions that did not respond to therapy and for persistent nodal disease, 
far higher LR rates ranging from 16% to 58%, and metastases ranging from 35% to 58% were 
reported. 
Neoadjuvant CRT followed by LE may represent a viable alternative to rectum extirpation 
in patients with low T2–3 rectal carcinoma. Despite an optimized surgical technique made 
available by total mesorectal excision, less favorable results were reported for tumors in the 
lower rectum. 
 
 
Fig. 20. Rectal cancer after neoadjuvant chemoradiation showing areas of fibrosis indicating 
good response 
The distal mesorectum, described by Morson (Morson et al., 1963) as a ‘‘bare area,’’ 
attenuates distally and is characterized by a circumferential decrease in healthy tissue 
surrounding the tumor, leading to a loss of tissue layers and a restricted field of view. For 
this region, incomplete mesorectal excision has been suggested as the cause of higher LR 
rates. 
Local full-thickness excision may be performed as an adequate therapeutic measure for 
complete response (CR) after nCRT. 
The described concept has been taken one step further by Habr-Gama (Habr-Gama et al., 
2004) who did not find a need for subsequent surgery in patients with clinically complete 
responses. In her retrospective, long-term, follow-up study which so far has remained 
unique, she reports a LR rate of only 3% in 100 patients.  
The question whether radical surgery, LE, or close-meshed follow-up alone may be 
appropriate in these patients, still remains largely unanswered. Furtherly it needs to be 
clarified, whether after nCRT with clinical confirmation of complete response, possibly 
remaining but vital tumor cells require surgical removal. These cells may have been 
damaged by irradiation and thus rendered unable to proliferate. Alternatively, some tumor 
cells surviving nCRT may represent resistant hypoxic clones that build the basis for 
development of recurrence later on. 
In summary, the findings of the revision made by Borschitz support the proposition, that the 
indication for LE after nCRT may be extended to distal cT2–3 rectal carcinoma. The 
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strongest prognostic parameter for favorable oncological outcomes is an effective tumor 
response without residual tumor (ypT0) or with response to at least the submucosa level 
(ypT1) in the excised specimen. For ypT2 tumors, the interpretation of the heterogeneous 
results should be performed with caution. But an extrapolation may be possible from LE 
alone, without nCRT. LE is not adequate in patients whose tumors exhibit no response or 
weak response to nCRT. These patients should be treated conventionally, that is, using 
radical surgery. 
 
 
Fig. 21. Rectal cancer after neoadjuvant chemoradiation showing complete response (ypT0) 
6. Conclusion 
Transanal Endoscopic Microsurgery is a fairly new variant of transanally performed surgery 
of the rectal cavity, developed in Germany during the 1980’s. In comparison to preceding 
techniques, it has largely expanded the spatial range and resolution of transanal procedures 
by employing state-of-the-art optics and endoscopic instruments, enabling the surgeon to 
reach parts of the rectum that were previously unaccessible by transanal approach. 
Repassing the findings throughout the manuscript, it is evidence based to conclude that 
TEM currently is and prospectively will be playing an important role in the management of 
lower rectal neoformations.   
When used in select cases of adenoma or low-grade adenocarcinoma and in accordance with 
the stringent indications governing more radical interventions, already in place, patients are 
due to benefit from less morbidity and mortality, including shorter recovery times.  
Within its constraints, TEM has also shown a more favorable incidence of local recurrences 
compared to standard transanal surgery, while being able to parallel local recurrence rates 
of more extended invasive interventions, like anterior resection and abdominoperineal 
approaches, outlining its qualities in curative treatment of rectal cancer. 
It has to be stressed, that the suitability of TEM must be determined in a meticulous 
preoperative staging and grading process, including MRI imaging and endorectal 
ultrasound, to tackle the thin red line separating availible approaches case by case. 
Apart from that, TEM may also serve as a last line measure for patients unfit or unwilling to 
undergo laparotomy, adding to its value in managing palliative instances.  
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Aditionally, in multimodal therapy schemes, including neoadjuvant chemoradiotherapy, the 
indication of TEM could expand, in the near future, to those patients showing a complete 
response. 
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